Other Consolidated Financial Statement Detail (Tables)

6 Months Ended

Jun. 30, 2012

Business [Abstract]

Other income (expense), net

	For the Three Months						For the Six Months
	Ended June 30,						Ended June 30,
(In millions)	2012			2011			2012			2011
Interest income	$	10.2		$	4.3		$	16.7		$	8.0
Interest expense		(7.0	)		(8.4	)		(14.4	)		(17.6	)
Impairments of investments		(0.8	)		(5.2	)		(1.3	)		(5.5	)
Gain (loss) on investments, net		2.5			(0.1	)		14.3			14.8
Foreign exchange gains (losses), net		(1.3	)		(0.6	)		0.1			(1.0	)
Other, net		(0.6	)		(1.7	)		2.7			(0.5	)
Total other income (expense), net	$	3.0		$	(11.7	)	$	18.1		$	(1.8	)

Accrued Expenses and Other

(In millions)	As of June 30, 2012		As of December 31, 2011
Employee compensation and benefits	$	156.7	$	176.3
Revenue-related rebates		132.9		115.0
Deferred revenue		110.3		69.6
Collaboration expenses		56.0		44.2
Clinical development expenses		50.1		40.8
Royalties and licensing fees		48.9		47.4
Current portion of contingent consideration obligations		16.9		10.8
Other		190.6		173.1
Total accrued expenses and other	$	762.4	$	677.2